Since June 2019, he has held a lifelong professorship for clinical translational sciences at the Berlin Institute of Health (BIH) and the Charité – Universitätsmedizin Berlin. The cancer expert leads the joint BIH and Charité Clinical Study Center as founding director and BIH chair. His research and work focuses on translational clinical research, molecular and gene therapy for cancer and hereditary diseases, hematology, oncology, short- and long-term hematopoiesis, cancer stem cells, retroviruses and digital medicine.